A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey

International Journal of Dermatology

Volumn 36, Issue 1, 1997, Pages 61-63

  Ozgoztasi, Orhan ^a,b   Baydar, Ibrahim ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

KETOCONAZOLE; METHYLBENZETHONIUM CHLORIDE; PAROMOMYCIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION; SKIN LEISHMANIASIS; TOPICAL DRUG ADMINISTRATION;

EID: 0030996657     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1997.00022.x     Document Type: Article

References (18)

1. El-On J, Livshin R, Even-Paz, et al. Topical treatment of cutaneous leishmaniasis. J Invest Dermatol 1986; 87: 284-288.
2. Weinrauch L, Cawich F, Craig P, et al. Topical treatment of new world cutaneous leishmaniasis in Belize: a clinical study. J Am Acad Dermatol 1993; 29: 443-446.
3. Grevelink SA, Lerner EA. Leishmaniasis. J Am Acad Dermatol 1996; 34: 257-272.
4. Berman JD. Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy and future strategies. Rev Infect Dis 1988; 10: 560-586.
5. Chulay JD, Spencer HC, Mugambi M. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate). Am J Trop Med Hyg 1985; 34: 702-709.
6. Koff AB, Rosen T. Treatment of cutaneous leishmaniasis. J Am Acad Dermatol 1994; 31: 693-708.
7. Belazzoug S, Neal RA. Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria. Trans R Soc Trop Med Hyg 1986; 80: 670-671.
8. Faris RM, Jarallah JS, Khoja TA, et al. Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony. Int J Dermatol 1993; 32: 610-612.
9. El-On J, Weinrauch L, Livshin R, et al. Topical treatment of recurrent cutaneous leishmaniasis with paromomycine-methyl benzothonium chloride ointment. Br J Dermatol 1985; 291: 704-705.
10. El-On J, Halevy S, Grunwald MH, et al. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study. J Am Acad Dermatol 1992; 27: 227-231.
11. El-Safi SH, Murphy AG, Bryceson ADM, et al. A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycine ointment. Trans R Soc Trop Med Hyg 1990; 84: 690-691.
12. Gramiccia M, Bettini S, Ya§arol S. Isoenzyme characterization of Leishmania isolates from human cases of cutaneous leishmaniasis in Urfa, south-east Turkey. Trans R Soc Trop Med Hyg 1984; 78: 568.
13. Carter KC, Alexander J, Baillie AJ. Studies on the topical treatment of experimental cutaneous leishmaniasis: the therapeutic effect of methyl benzothonium chloride and aminoglycosides, gentamicin and paromomycine. Ann Trop Med Parasitol 1989; 82: 233-239.
14. Saenz RE, Paz H, Berman JD. Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis. Am J Med 1990; 89: 147-155.
15. Navin TR, Arana BA, Arana FE, et al. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis 1992; 165: 528-534.
16. Weinrauch L, Livshin R, El-On J. Ketoconazole in cutaneous leishmaniasis. Br J Dermatol 1987; 117: 666-668.
17. Norton SA, Frankenburg S, Klaus SN. Cutaneous leishmaniasis acquired during military service in the middle east. Arch Dermatol 1992; 128: 83-87.
18. Berman JD, Holz GG, Beach DH. Effects of ketoconazole on growth and sterol biosynthesis of Leishmania mexicana promastigotes in culture. Mol Biochem Parastiol 1984; 12: 1-13.